Market Share of Global Attention Deficit Hyperactivity Disorder Industry
The attention deficit hyperactivity disorder market is moderately competitive owing to the presence of multiple players. The players in the market are adopting strategies like product innovation, mergers, and acquisitions in order to expand their product portfolio and expand their geographic reach and primarily to stay competitive in the market. Some of the vendors in the market are Eli Lily & Company, Pfizer, Johnson & Johnson Services LLC, Lupin, Shire, Mallinckrodt, Prude Pharma L.P., and NEOS Therapeutics Inc.
Attention Deficit Hyperactivity Disorder Market Leaders
Eli Lily & Company
Pfizer
Lupin
Mallinckrodt
Purdue Pharma L.P
*Disclaimer: Major Players sorted in no particular order
